Aviva’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,712
Closed -$949K 1037
2022
Q4
$949K Sell
11,712
-8,300
-41% -$696K ﹤0.01% 887
2022
Q3
$1.52M Buy
20,012
+1,697
+9% +$163K 0.01% 779
2022
Q2
$2M Buy
18,315
+2,600
+17% +$276K 0.01% 813
2022
Q1
$1.56M Sell
15,715
-10,836
-41% -$1.03M 0.01% 896
2021
Q4
$2.54M Buy
26,551
+11,929
+82% +$1.2M 0.01% 788
2021
Q3
$1.62M Buy
+14,622
New +$1.67M 0.01% 848
2020
Q2
Sell
-7,265
Closed -$501K 967
2020
Q1
$501K Sell
7,265
-9,010
-55% -$950K ﹤0.01% 897
2019
Q4
$1.86M Buy
+16,275
New +$2.03M 0.01% 803

Other funds holding USPH

Aviva's USPH Position: Q1 2023 in Review

Aviva sold out of US Physical Therapy (USPH) in Q1 2023, closing a stake of 11,712 shares — an estimated $949K sold.

Aviva first reported a position in USPH in Q4 2019 and held it in 8 quarters. The position peaked at $2.54M in Q4 2021. 200 funds tracked by Wall St. Rank hold USPH as of Q1 2023.

  • Aviva reported no remaining US Physical Therapy position as of Q1 2023 after selling out during the quarter.
  • Aviva sold 11,712 US Physical Therapy shares in Q1 2023, an estimated $949K.
  • Aviva first reported a position in US Physical Therapy in Q4 2019 and held it in 8 quarters.
  • Aviva's US Physical Therapy position peaked at $2.54M in Q4 2021.
  • 200 funds tracked by Wall St. Rank held US Physical Therapy as of Q1 2023.

Based on Aviva's 13F filing for Q1 2023, filed 12 May 2023.